東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Oxidative stress in cardiovascular-metabolic diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Oxidative stress in cardiovascular-metabolic diseases/ edited by Ali Hussein Eid, Firas Kobeissy, Ahmed F. El-Yazbi.
其他作者:	Eid, Ali Hussein.
出版者:	Cham :Springer Nature Switzerland : : 2024.,
面頁冊數:	xii, 298 p. :ill. (some col.), digital ;24 cm.
內容註:	Chapter 1 - Interplay between ROS and gender in the pathogenesis of cardiovascular disease -- chapter 2 -ROS, aging and cardiovascular disease -- Chapter 3 - Combat ROS, prevent CVD -- Chapter 4 -Traumatic-brain injury and CVD: ROS is the link? -- Chapter 5 - Adipose tissue inflammation and CVD: oxidative stress as a catalyst -- Chapter 6 - Oxidative stress in diabetes-compounded CVD -- Chapter 7 - ROS in hypertension: a critical update -- Chapter 8 - ROS in atherosclerosis: what we know -- Chapter 9 - ROS as a key mediator of cardiovasculometabolic disease -- Chapter 10 - Antioxidant Therapy in CVD: hope or hype? -- Chapter 11 - Antioxidants as adjuvant therapy: Evidence from clinical trials.
Contained By:	Springer Nature eBook
標題:	Active oxygen in the body. -
電子資源:	https://doi.org/10.1007/978-3-031-62131-4
ISBN:	9783031621314

Oxidative stress in cardiovascular-metabolic diseases
Oxidative stress in cardiovascular-metabolic diseases[electronic resource] /edited by Ali Hussein Eid, Firas Kobeissy, Ahmed F. El-Yazbi. - Cham :Springer Nature Switzerland :2024. - xii, 298 p. :ill. (some col.), digital ;24 cm. - Oxidative stress in applied basic research and clinical practice,2197-7232. - Oxidative stress in applied basic research and clinical practice..

Chapter 1 - Interplay between ROS and gender in the pathogenesis of cardiovascular disease -- chapter 2 -ROS, aging and cardiovascular disease -- Chapter 3 - Combat ROS, prevent CVD -- Chapter 4 -Traumatic-brain injury and CVD: ROS is the link? -- Chapter 5 - Adipose tissue inflammation and CVD: oxidative stress as a catalyst -- Chapter 6 - Oxidative stress in diabetes-compounded CVD -- Chapter 7 - ROS in hypertension: a critical update -- Chapter 8 - ROS in atherosclerosis: what we know -- Chapter 9 - ROS as a key mediator of cardiovasculometabolic disease -- Chapter 10 - Antioxidant Therapy in CVD: hope or hype? -- Chapter 11 - Antioxidants as adjuvant therapy: Evidence from clinical trials.

The book dissects the role of oxidative stress in the pathogenesis of the leading causes of global morbidity and mortality, i.e.cardiovascular and metabolic diseases. The chapters discuss topics related to the role reactive oxygen species (ROS) play in hypertension, atherosclerosis,diabetes, obesity and related pathologies. The authors also shed light on gender differences in the onset and pathologies of some of these diseases. Moreover, how ROS and aging interplay to precipitate cardiovasculo-metabolic disease is discussed and highlighted. Preventive measures that can abrogate ROS-induced cardiovasclo-metabolic disease are discussed and clarified in the hope of reducing such a debilitating battery of diseases. A section dedicated to antioxidants as potential therapy is also included. Furthermore, given the complexity of the mechanisms implicated in ROS-modulated responses, it remains challenging to assert a conclusive argument and pre-determined regimen for incorporating antioxidants into conventional therapies. Nonetheless, results from some clinical trials appear promising, warranting the addition of a chapter dedicated to such human trials. In all of the chapters, the molecular, cellular, genetic, and pharmacological mechanisms implicated are covered from an applied science perspective. This is an ideal book for basic researchers in the biomedical field, graduate students in biological and biomedical fields, medical students, instructors in medical and graduate schools, and professionals working for pharmaceutical companies.

ISBN: 9783031621314

Standard No.: 10.1007/978-3-031-62131-4doiSubjects--Topical Terms:

558959
Active oxygen in the body.

LC Class. No.: RC669.9

Dewey Class. No.: 616.1

Oxidative stress in cardiovascular-metabolic diseases
LDR:03411nmm a22003495a 4500 001 2387758
003 DE-He213
005 20240808130242.0
006 m d
007 cr nn 008maaau
008 250916s2024 sz s 0 eng d
020 $a 9783031621314 $q (electronic bk.)
020 $a 9783031621307 $q (paper)
024 7 $a 10.1007/978-3-031-62131-4 $2 doi
035 $a 978-3-031-62131-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC669.9
072 7 $a PSF $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a PSF $2 thema
082 0 4 $a 616.1 $2 23
090 $a RC669.9 $b .O98 2024
245 0 0 $a Oxidative stress in cardiovascular-metabolic diseases $h [electronic resource] / $c edited by Ali Hussein Eid, Firas Kobeissy, Ahmed F. El-Yazbi.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xii, 298 p. : $b ill. (some col.), digital ; $c 24 cm.
347 $a text file $b PDF $2 rda
490 1 $a Oxidative stress in applied basic research and clinical practice, $x 2197-7232
505 0 $a Chapter 1 - Interplay between ROS and gender in the pathogenesis of cardiovascular disease -- chapter 2 -ROS, aging and cardiovascular disease -- Chapter 3 - Combat ROS, prevent CVD -- Chapter 4 -Traumatic-brain injury and CVD: ROS is the link? -- Chapter 5 - Adipose tissue inflammation and CVD: oxidative stress as a catalyst -- Chapter 6 - Oxidative stress in diabetes-compounded CVD -- Chapter 7 - ROS in hypertension: a critical update -- Chapter 8 - ROS in atherosclerosis: what we know -- Chapter 9 - ROS as a key mediator of cardiovasculometabolic disease -- Chapter 10 - Antioxidant Therapy in CVD: hope or hype? -- Chapter 11 - Antioxidants as adjuvant therapy: Evidence from clinical trials.
520 $a The book dissects the role of oxidative stress in the pathogenesis of the leading causes of global morbidity and mortality, i.e.cardiovascular and metabolic diseases. The chapters discuss topics related to the role reactive oxygen species (ROS) play in hypertension, atherosclerosis,diabetes, obesity and related pathologies. The authors also shed light on gender differences in the onset and pathologies of some of these diseases. Moreover, how ROS and aging interplay to precipitate cardiovasculo-metabolic disease is discussed and highlighted. Preventive measures that can abrogate ROS-induced cardiovasclo-metabolic disease are discussed and clarified in the hope of reducing such a debilitating battery of diseases. A section dedicated to antioxidants as potential therapy is also included. Furthermore, given the complexity of the mechanisms implicated in ROS-modulated responses, it remains challenging to assert a conclusive argument and pre-determined regimen for incorporating antioxidants into conventional therapies. Nonetheless, results from some clinical trials appear promising, warranting the addition of a chapter dedicated to such human trials. In all of the chapters, the molecular, cellular, genetic, and pharmacological mechanisms implicated are covered from an applied science perspective. This is an ideal book for basic researchers in the biomedical field, graduate students in biological and biomedical fields, medical students, instructors in medical and graduate schools, and professionals working for pharmaceutical companies.
650 0 $a Active oxygen in the body. $3 558959
650 0 $a Cardiovascular system $x Diseases $x Molecular aspects. $3 907466
650 0 $a Metabolism $x Disorders $x Molecular aspects. $3 2145885
650 1 4 $a Cellular Stress. $3 3531329
650 2 4 $a Cell Biology. $3 892383
650 2 4 $a Cardiovascular Physiology. $3 773622
650 2 4 $a Metabolism. $3 541349
650 2 4 $a Molecular Biology. $3 600567
700 1 $a Eid, Ali Hussein. $3 3752413
700 1 $a Kobeissy, Firas. $3 3718453
700 1 $a El-Yazbi, Ahmed F. $3 3752414
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Oxidative stress in applied basic research and clinical practice. $3 1566322
856 4 0 $u https://doi.org/10.1007/978-3-031-62131-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)